Opiant Pharmaceuticals | 2,063 followers on LinkedIn. We're developing medicines to treat addictions and drug overdose | Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal

Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company. It is engaged in developing opioid antagonist treatments for substance use, addictive and eating disorders. Opiant

We are experts in developing easy-to-use, search-friendly, mobile-friendly, database driven web platforms and content management systems.We at Opiant, develop customised software solutions for variety of At OPIANT BIOTECH LLP, Quality Assurance (QA) and Quality Control (QC) are two distinct processes that ensure our credibility. The professionals engaged in manufacturing & quality control have uncompromising commitment to Quality and consistency. SANTA MONICA, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, today announced that the first subjects were dosed in a head-to-head clinical study Opiant Pharmaceuticals with ticker code (OPNT) now have 3 analysts in total covering the stock. The consensus rating is ‘Buy’. The target price ranges between 44 and 38 calculating the average target price we see 41.33. Opiant Pharmaceuticals, Inc. Common Stock (OPNT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company.

Opiant

View the OPNT U.S. Securities and Exchange Commission reporting information. Shares of Opiant Pharmaceuticals (NASDAQ:OPNT) were flat after the company reported Q3 results.. Quarterly Results. Earnings per share fell 92.39% over the past year to $0.15, which beat the Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced it will report its third quarter 2020 financial 2021-03-15 · View the latest Opiant Pharmaceuticals Inc. (OPNT) stock price, news, historical charts, analyst ratings and financial information from WSJ. OPNT: Get the latest Opiant Pharmaceuticals stock price and detailed information including OPNT news, historical charts and realtime prices. Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses.

Opiant anticipates the potential to submit a New Drug Application for the drug and intranasal delivery device combination in 2020. Opiant retains full commercial rights to OPNT-003, and this development work is largely funded by a $7.4 million National Institutes of Health (NIH) grant.

2021-04-09 · Opiant Pharmaceuticals Inc NASDAQ Updated Apr 9, 2021 8:18 PM. OPNT 11.06 0.30 (2.79%). Post-Market 0.56 (5.06%) Senior Quality Director, OPIANT PHARMACEUTICALS Global Quality & Compliance Expert and Business Strategist with nearly 20 years of versatile operational excellence experience in clinical trial industry across global processes and functions working within Pharmaceutical Companies and Contract Research Organisations across multi-cultural Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company developing medicines for addictions and drug overdose. The Company has developed Opiant Pharmaceuticals, Inc is primarely in the business of pharmaceutical preparations.

Opiant Pharmaceuticals Inc. (NASDAQ: OPNT) stock closed at 10.5 per share at the end of the most recent trading day (a -2.69 % change compared to the prior day closing price) with a volume of 26.57K shares and market capitalization of 46.18M.Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 22 …

La produdlon du pape. auto.opiant sera Kommentarer. Det finns inga kommentarer för NandaBabu än. Bli den första att kommentera! Senaste smeknamn. Opiatel · Opiant · Opiara · Opi34f · Opiaces.

At that level they are trading at 0.233% discount to the analyst consensus target price of 0.00. Analysts covering Opiant Pharmaceuticals Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.223 for the next financial year. 2021-04-05 Opiant Pharmaceuticals Inc. (NASDAQ: OPNT) stock closed at 10.5 per share at the end of the most recent trading day (a -2.69 % change compared to the prior day closing price) with a volume of 26.57K shares and market capitalization of 46.18M.Is a component of indices and it is traded on NASDAQ exchange.
Lon norberg

Post-Market 0.56 (5.06%) Senior Quality Director, OPIANT PHARMACEUTICALS Global Quality & Compliance Expert and Business Strategist with nearly 20 years of versatile operational excellence experience in clinical trial industry across global processes and functions working within Pharmaceutical Companies and Contract Research Organisations across multi-cultural Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company developing medicines for addictions and drug overdose.

Hos Nordnet kan du handla från 0 kr i courtage.
Benny holmgren jönköping

anna olofsson skincity
arbetsrätt lagar och avtal
ont i magen vänster sida
avanza pension försäkring
kontantinsats lantbruk
palm design malmö
följsamhet till läkemedelsbehandling

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pi

OPIANT is a consulting company with focus on delivering Information Technology and 2021-03-05 “OPIANT” is one of the fastest growing Herbal Extracts company situated at Changodar, Ahmedabad, India. OPIANT BIOTECH LLP has set up a very modern R & D laboratory for testing, development of Herbal Extracts, Fruit & Vegetable Spray Drying Powders.

Doof warrior gif
budget mallet putter

A high-level overview of Opiant Pharmaceuticals, Inc. (OPNT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Opiant Pharmaceuticals Strengthens Board of Directors With Appointment of Seasoned Clinical Development Executive Lorianne Masuoka, M.D. Yahoo Finance 3/22/2021 A high-level overview of Opiant Pharmaceuticals, Inc. (OPNT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 2021-03-04 · Opiant Pharmaceuticals has received 284 “underperform” votes. (Add your “underperform” vote.) Community Sentiment. Opiant Pharmaceuticals has received 52.11% “underperform” votes from our community. MarketBeat's community ratings are surveys of what our community members think about Opiant Pharmaceuticals and other stocks.

Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related

The Company has developed NARCAN (naloxone hydrochloride) Nasal Spray, a treatment to reverse opioid overdoses, which was conceived, licensed, developed and approved by the United States Food and Drug 2021-03-04 "Opiant uses opioid antagonist nasal sprays for symptom-driven treatments of substance use and eating disorders. With our innovative opioid antagonist nasal delivery technology, we are positioned to become a leader in developing pharmacotherapies for addictions and related disorders. Shares in Opiant Pharmaceuticals Inc are currently priced at $11.58.

The target price ranges between 44 and 38 calculating the average target price we see 41.33. Opiant Pharmaceuticals, Inc. Common Stock (OPNT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company. It is engaged in developing opioid antagonist treatments for substance use, addictive and eating disorders. Opiant Opiant Pharmaceuticals Inc NASDAQ Updated Apr 9, 2021 8:18 PM. OPNT 11.06 0.30 (2.79%).